Top Markets
Coin of the day
Gongwin Biopharm Holdings Co., Ltd. Gongwin Biopharm Holdings Co., Ltd.

Gongwin Biopharm Holdings Co., Ltd.

6617
Rang in aandelen #13752
Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical... Gongwin Biopharm Holdings Co., Ltd. is a clinical-stage biopharmaceutical company specializing in the development of oncology therapeutics. The company's robust pipeline features several drug candidates, including PTS302, which has successfully concluded Phase III clinical trials for lung cancer. Additionally, PTS100 is currently progressing through Phase II clinical trials for liver cancer, while PTS-02 is being developed to address adenoid cystic carcinoma, and PTS500 targets malignant pleural effusion. Established in 2014, Gongwin Biopharm is headquartered in Taipei, Taiwan.
Aandeelprijs
$3.83
Marktkapitalisatie
$464.45M
Verandering (1 dag)
-1.63%
Verandering (1 jaar)
17.17%
Land
TW
Handel Gongwin Biopharm Holdings Co., Ltd. (6617)

Categorie

Koersgeschiedenis voor Gongwin Biopharm Holdings Co., Ltd. (6617)
Hoogste slotkoers: $3.43 op 2026-08-01

Laagste slotkoers: $2.71 op 2017-02-01
Koersgeschiedenis van Gongwin Biopharm Holdings Co., Ltd. van 2017 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -1.11%
2025 -19.11%
2024 -45.63%
2023 -41.34%
2022 10.61%
2021 7.85%
2020 318.74%
2019 -1.25%
2018 12.21%
2017 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$885.01 28.89%
US
$323.36 10.89%
US
$234.55 57.65%
US
$187.22 0.00%
US
$1.90 -7.01%
AU